Citybuzz

Citybuzz

Citybuzz is a vibrant local lifestyle and news media outlet. While primarily reporting on community events and entertainment it also actively covers business innovation and tech trends acting as a window connecting local audiences with modern digital lifestyle trends.

Citybuzz's Articles

222websites.com Expands Custom Web Design and Local SEO Services to Six West Virginia Cities

222websites.com Expands Custom Web Design and Local SEO Services to Six West Virginia Cities

222websites.com expands custom small business web design and local SEO to 6 WV cities: Charleston, Huntington, Morgantown, Parkersburg, Beckley, Martinsburg. 1-

Demand & Convert Deploys Proprietary Web Architecture to Help Local Trades Escape Shared Lead Model

Demand & Convert Deploys Proprietary Web Architecture to Help Local Trades Escape Shared Lead Model

Demand & Convert launches proprietary web architecture to help tradespeople escape shared lead models, build owned pipelines, and boost profitability with mobile

LakeShore Biopharma Completes Going Private Transaction, Ceases Public Trading

LakeShore Biopharma Completes Going Private Transaction, Ceases Public Trading

LakeShore Biopharma completes going-private merger with Oceanpine Skyline, delisting from OTC markets. Shareholders receive $0.066 per share. The biopharmaceutical

VERAXA Biotech Reports Proof-of-Concept Data for BiTAC-ADC Platform, Seeks Partnerships at BIO 2026

VERAXA Biotech Reports Proof-of-Concept Data for BiTAC-ADC Platform, Seeks Partnerships at BIO 2026

VERAXA Biotech (VRXA) announces new in vitro data for BiTAC-ADC platform, showing selective cancer cell destruction. Company to seek partnerships at BIO 2026. The

Greenland Energy Advances Jameson Land Basin Toward Exploration Drilling, CEO Says

Greenland Energy Advances Jameson Land Basin Toward Exploration Drilling, CEO Says

Greenland Energy (NASDAQ: GLND) advances Jameson Land Basin oil project with 13 billion barrel potential, targeting October 2026 drilling. CEO Robert Price discusses

Cancer Nanomedicine Gains Momentum as Onco-Innovations Advances PNKP Inhibitor Platform

Cancer Nanomedicine Gains Momentum as Onco-Innovations Advances PNKP Inhibitor Platform

Onco-Innovations (ONCO, ONNVF) advances cancer nanomedicine with ONC010, a PNKP inhibitor using polymer nanodelivery for improved tumor targeting and tolerability

Quantum BioPharma Advances Novel MS Therapy Targeting Myelin Repair into Phase 2 Trials

Quantum BioPharma Advances Novel MS Therapy Targeting Myelin Repair into Phase 2 Trials

Quantum BioPharma's Lucid-MS enters phase 2 trials to halt multiple sclerosis progression. Learn how this novel therapy targets myelin repair, offering hope for

Precious Metals Rally as Gold and Silver Prices Surge, Driven by Four Key Forces

Precious Metals Rally as Gold and Silver Prices Surge, Driven by Four Key Forces

Precious metals rally as gold hits $4,362/oz and silver $71.2/oz. Key forces driving this surge include inflation and geopolitics. New Pacific Metals could benefit

Next-Generation DNA Repair Inhibitors Poised to Capture Billions in Growing Oncology Market

Next-Generation DNA Repair Inhibitors Poised to Capture Billions in Growing Oncology Market

Onco-Innovations advances ONC010, a nanoparticle PNKP inhibitor, in the growing DDR inhibitor market. Learn how this precision medicine approach targets cancer

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma advances Lucid-MS, a first-in-class drug for multiple sclerosis that protects myelin. Phase 2 trial preparation underway after successful safety